Senior insider sale
CMO at EDGEWISE THERAPEUTICS, INC. — senior position signals high conviction
$3.85M
121.59K shares
What this filing means
DONOVAN JOANNE M. plans to sell 121.59K shares of EDGEWISE THERAPEUTICS, INC. valued at approximately $3.85M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/5/2026ACC: 0001950047-26-004054
Officer· CMO
Since Apr 2021
121.59K
Shares to sell
$3.85M
Approx. market value
50K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
5/5/2026
50KTotal acquired50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/5/2026 | Exercise of Stock Options Cash | 50K | — |
| Total | 50K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
5.23K
Market value
$163.7K
5/4/2026
—Completed
Units to sell
28.66K
Market value
$926.1K
4/1/2026
—Completed
Units to sell
21.34K
Market value
$685.3K
3/31/2026
—Completed
Units to sell
16.36K
Market value
$506.7K
3/27/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
50K
Market value
$1.57M
5/5/2026
Total
Units
121.59K
Value
$3.85M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/4/2026 | 5.23K | $163.7K | — | Completed |
4/1/2026 | 28.66K | $926.1K | — | Completed |
3/31/2026 | 21.34K | $685.3K | — | Completed |
3/27/2026 | 16.36K | $506.7K | — | Completed |
| Planned — Approximate Date | ||||
5/5/2026 | 50K | $1.57M | NASDAQ | Planned |
| Total | 121.59K | $3.85M | ||